Adamas Pharmaceuticals
ADMS
#7623
Rank
ยฃ0.28 B
Marketcap
ยฃ6.17
Share price
0.00%
Change (1 day)
15,633.51%
Change (1 year)

Revenue for Adamas Pharmaceuticals (ADMS)

Revenue in 2021 (TTM): ยฃ64.53 Million

According to Adamas Pharmaceuticals 's latest financial reports the company's current revenue is ยฃ66.19 Million. In 2020 the company made a revenue of ยฃ55.89 Million an increase over the revenue in the year 2019 that were of ยฃ41.01 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Adamas Pharmaceuticals from 2013 to 2021

Annual revenue

Year Revenue Change
2021 (TTM)ยฃ64.53 M15.46%
2020ยฃ55.89 M36.28%
2019ยฃ41.01 M60.48%
2018ยฃ25.55 M
2016ยฃ0.42 M-70.15%
2015ยฃ1.43 M-96.57%
2014ยฃ41.92 M-21.45%
2013ยฃ53.36 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Zogenix
ZGNX
ยฃ61.32 M-7.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Supernus Pharmaceuticals
SUPN
ยฃ0.51 B 672.82%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
ยฃ44.77 B 67,532.02%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
ยฃ31.79 B 47,925.01%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
ยฃ48.21 B 72,737.88%๐Ÿ‡บ๐Ÿ‡ธ USA